These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35583359)

  • 41. Cepheid Xpert
    Wabe N; Lindeman R; Post JJ; Rawlinson W; Miao M; Westbrook JI; Georgiou A
    Influenza Other Respir Viruses; 2021 Mar; 15(2):245-253. PubMed ID: 32815622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
    Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses.
    Ling L; Kaplan SE; Lopez JC; Stiles J; Lu X; Tang YW
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative evaluation of the Thermo fisher TaqPath™ COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens.
    Granato PA; Kimball SR; Alkins BR; Cross DC; Unz MM
    BMC Infect Dis; 2021 Jun; 21(1):623. PubMed ID: 34193072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system.
    Paradis S; Lockamy E; Cooper CK; Young S
    J Clin Virol; 2021 Oct; 143():104946. PubMed ID: 34507269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Evaluation of Xpert Xpress CoV-2/Flu/RSV
    Chan WS; Wong KP; Yau SK; Wong CY; Chan TC; Hung J; Lai KT; Leung CP; Wang CL; Au CH; Wan TS; Ma ES; Tang BS
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the Seegene Allplex™ RV master assay for one-step simultaneous detection of eight respiratory viruses in nasopharyngeal specimens.
    Mdunyelwa A; Seema C; Mabaso A; Mlambo K; Mtsweni M; Maphanga M; Rammutla E; Tempelman HA; Umunnakwe CN
    J Virol Methods; 2025 Jan; 331():115042. PubMed ID: 39384158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus.
    Kim TY; Kim JY; Shim HJ; Yun SA; Jang JH; Huh HJ; Kim JW; Lee NY
    J Virol Methods; 2021 Dec; 298():114304. PubMed ID: 34592335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influenza A, Influenza B, human respiratory syncytial virus and SARSCoV-2 molecular diagnostics and epidemiology in the post COVID-19 era.
    Luštrek M; Cesar Z; Suljič A; Kogoj R; Knap N; Virant MJ; Uršič T; Petrovec M; Avšič-Županc T; Korva M
    Respir Res; 2024 Jun; 25(1):234. PubMed ID: 38840154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of Saliva Swab for Detection of Influenza Virus in Patients Admitted to an Emergency Department.
    Galar A; Catalán P; Vesperinas L; Miguens I; Muñoz I; García-Espona A; Sevillano JA; Andueza JA; Bouza E; Muñoz P
    Microbiol Spectr; 2021 Sep; 9(1):e0033621. PubMed ID: 34431684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
    Graham M; Williams E; Isles N; Buadromo E; Toatu T; Druce J; Catton M; Lin C; Howden BP; Williamson DA
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115238. PubMed ID: 33171384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic Accuracy of the LabTurbo QuadAIO Common Flu Assay for Detecting Influenza A Virus, Influenza B Virus, RSV, and SARS-CoV-2.
    Tai CS; Jian MJ; Lin TH; Chung HY; Chang CK; Perng CL; Hsieh PS; Shang HS
    Diagnostics (Basel); 2024 Oct; 14(19):. PubMed ID: 39410604
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
    Lee J; Song JU
    J Med Virol; 2021 Jul; 93(7):4523-4531. PubMed ID: 33913533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays.
    Quinton M; Geahr M; Gluck L; Jarrett J; Mostafa HH
    J Clin Virol; 2022 Jun; 150-151():105164. PubMed ID: 35468544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the fully automated, sample-to-result Seegene STARlet-AIOS platform for detection of SARS-CoV-2, influenza virus A, influenza virus B, and RSV.
    Brouwer CWE; Russcher A; Rezek Y; Nijhuis RHT
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):87-93. PubMed ID: 37966626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay.
    Isles N; Badman SG; Ballard S; Zhang B; Howden BP; Guy R; Williamson DA
    Pathology; 2022 Feb; 54(1):120-122. PubMed ID: 34776245
    [No Abstract]   [Full Text] [Related]  

  • 57. Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation.
    Brendish NJ; Davis C; Chapman ME; Borca F; Waddington D; Hill C; White N; Clark TW
    J Infect; 2024 Jan; 88(1):41-47. PubMed ID: 37977337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2.
    Malczynski M; Rezaeian S; Rios J; Dirnberger L; Polanco W; Zembower T; Qi C
    Access Microbiol; 2020; 2(12):acmi000176. PubMed ID: 33490871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-Center Experience in Detecting Influenza Virus, RSV and SARS-CoV-2 at the Emergency Department.
    Nairz M; Todorovic T; Gehrer CM; Grubwieser P; Burkert F; Zimmermann M; Trattnig K; Klotz W; Theurl I; Bellmann-Weiler R; Weiss G
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2.
    Park J; Kim SY; Lee J; Hong KH
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.